Ibex Medical Analytics
IBEX develops a product suite to improve clinical decision-making and to streamline pathology laboratory workflows.
Ibex Medical Analytics has raised €42M across 2 funding rounds from 3 investors, most recently a Series B round in Mar 2021. Based in Tel Aviv, Israel; founded 2016; active in Software and Healthtech. Data as of 28 Oct 2026.
Total raised
€42M
€41,631,258
Funding rounds
2
Investors
3
distinct backers
Active since
2019-01
latest 2021-03
Funding by year
EUR raised per yearIbex Medical Analytics — funding by year — interactive chart.
Data table
| Ibex Medical Analytics — funding by year | |
|---|---|
| 2018 | €9.6M |
| 2021 | €32M |
Signals
High confidenceRaise-next likelihood11
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-03-09 | Series B | €32M | 83North,Octopus Ventures | View deal → |
| 2019-01-01 | Series A | €9.6M | aMoon Fund | View deal → |
Investors
3Related news
Similar companies
same sector or country- DAZN€3.8BUK · Software
- Visma€3.0BNorway · Software
- Celonis€2.2BGermany · Software
- Bending Spoons€1.7BItaly · Software
- UiPath€1.7BRomania · AI
- ContentSquare€1.3BFrance · Software
Global coverage: FundingData